<DOC>
	<DOCNO>NCT01146821</DOCNO>
	<brief_summary>The primary objective trial determine safety efficacy IV fish oil dose 0.20 g/kg 0.50 g/kg , compare control group , critically ill patient severe sepsis examine organ function , blood safety biochemical parameter , marker systemic inflammation innate immunological parameter</brief_summary>
	<brief_title>Fish OIL Optimal dosE Determination Study</brief_title>
	<detailed_description>Objectives : The overall objective determine effect IV fish oil 28-day mortality critically ill patient severe sepsis . However , prior large trial , need determine optimal dose IV fish oil population . Therefore , primary objective proposal ( FOILED ) determine safety efficacy IV fish oil dose 0.20 g/kg 0.50 g/kg , compare control group , critically ill patient severe sepsis examine organ function , blood safety biochemical parameter , marker systemic inflammation innate immunological parameter . Study Design : This multi-centre , open-label , phase I dose range clinical trial prospective control . Setting : 2 tertiary care ICUs Germany ( Universit√§tsklinikum Carl Gustav Carus , Dresden University Hospital Giessen Marburg , Giessen ) . Patients : Mechanically ventilate adult patient ( &gt; 18 year old ) admit ICU clinical evidence sepsis , sepsis associate organ dysfunction , high expression inflammatory cytokine .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<criteria>Adult ICU patient Requiring invasive noninvasive ventilation Clinical evidence sepsis Presence one organ failures &gt; 24 hour admission ICU time consent Low level inflammatory cytokine ( IL6 ( qualitative assay &lt; 100 pg/ml ) lack commitment full aggressive care ( anticipated withholding withdraw treatment first week ) Immunocompromised ( postorgan transplantation , HIV , neutropenic [ &lt; 1000 PMN ] , steroids &gt; 20 mgs/day 6 month ) . Chronic noninvasive ventilation ( except become mechanically ventilated ) Platelet count &lt; 30 GPt/L Pregnant patient . Urine/blood test pregnancy do woman childbearing age site part standard ICU practice . Previous enrollment study Enrollment ICU intervention study Allergy fish fish oil ( shellfish allergy exclusion criterion ) Has already receive enteral IV omega3 fatty acid hospitalization current ICU admission .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>